VSee Health, Inc. VSEED
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -52.13% | -1.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -52.13% | -1.38% | |||
| Cost of Revenue | -44.93% | 9.66% | |||
| Gross Profit | -60.34% | -11.53% | |||
| SG&A Expenses | -54.74% | 27.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -51.95% | 21.98% | |||
| Operating Income | 51.75% | -67.16% | |||
| Income Before Tax | 84.09% | -2,592.41% | |||
| Income Tax Expenses | -53.97% | -- | |||
| Earnings from Continuing Operations | 83.90% | -2,609.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.88% | -2,609.84% | |||
| EBIT | 51.75% | -67.16% | |||
| EBITDA | 63.74% | -98.04% | |||
| EPS Basic | 78.81% | -1,333.29% | |||
| Normalized Basic EPS | 86.72% | -1,314.42% | |||
| EPS Diluted | 78.81% | -1,333.29% | |||
| Normalized Diluted EPS | 86.72% | -1,314.42% | |||
| Average Basic Shares Outstanding | 56.30% | 89.03% | |||
| Average Diluted Shares Outstanding | 56.30% | 89.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||